As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma, biotech, and industrial biology. Ainnocence is expanding partnerships, ...

Despite 700% net product revenue growth to $113 million, ImmunityBio's high debt load and unprofitability remain significant ...

Scientists have turned to artifacts associated with Leonardo da Vinci on a quest to track down the legendary polymath’s ...

An international group of researchers led by Pompeu Fabra University has discovered the nanomachine that controls ...

A new discovery about how cells communicate with each other in the body's immune system has revealed deeper insights for an ...

Going into 2026, biotech company Ladder Bio is embracing a new identity.

With widespread outrage over missed appointments, no GPS, and the inability to log in to work apps, many say a $20 credit is ...

ImmunityBio (IBRX) stock rises as the company records over 400% YoY groiwth in Q4 net product revenue thanks to its cancer ...

Detailed price information for Bridgebio Oncology Therapeutics Inc (BBOT-Q) from The Globe and Mail including charting and trades.

Aesthetic doctor Dr David Jack is keen to point out though, that it’s “relatively difficult to stabilise very high ...

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, " Stem Cell Therapy ...

The global synthetic biology and biomanufacturing market is poised for exceptional growth by 2036, driven by the adoption of sustainable bio-based production methods across industries. Key ...